BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Górski A, Bollyky PL, Przybylski M, Borysowski J, Międzybrodzki R, Jończyk-Matysiak E, Weber-Dąbrowska B. Perspectives of Phage Therapy in Non-bacterial Infections. Front Microbiol 2018;9:3306. [PMID: 30687285 DOI: 10.3389/fmicb.2018.03306] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zeinali T, Faraji N, Joukar F, Khan Mirzaei M, Kafshdar Jalali H, Shenagari M, Mansour-ghanaei F. Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105704] [Reference Citation Analysis]
2 Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 2021;19:55-71. [PMID: 32887946 DOI: 10.1038/s41579-020-0433-9] [Cited by in Crossref: 125] [Cited by in F6Publishing: 117] [Article Influence: 62.5] [Reference Citation Analysis]
3 Górski A, Międzybrodzki R, Żaczek M, Borysowski J. Phages in the fight against COVID-19? Future Microbiol 2020;15:1095-100. [PMID: 32845164 DOI: 10.2217/fmb-2020-0082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
4 Raghavan V, Aquadro CF, Alani E. Baker's Yeast Clinical Isolates Provide a Model for How Pathogenic Yeasts Adapt to Stress. Trends Genet 2019;35:804-17. [PMID: 31526615 DOI: 10.1016/j.tig.2019.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
5 Łusiak-Szelachowska M, Międzybrodzki R, Fortuna W, Borysowski J, Górski A. Anti-phage serum antibody responses and the outcome of phage therapy. Folia Microbiol (Praha) 2021;66:127-31. [PMID: 33126265 DOI: 10.1007/s12223-020-00835-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Mishra VN, Kumari N, Pathak A, Chaturvedi RK, Gupta AK, Chaurasia RN. Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection. Int J Microbiol 2020;2020:8844963. [PMID: 32963540 DOI: 10.1155/2020/8844963] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sinha A, Maurice CF. Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune System. Mediators Inflamm 2019;2019:3730519. [PMID: 31582898 DOI: 10.1155/2019/3730519] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
8 Dailey PJ, Elbeik T, Holodniy M. Companion and complementary diagnostics for infectious diseases. Expert Rev Mol Diagn 2020;20:619-36. [PMID: 32031431 DOI: 10.1080/14737159.2020.1724784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Khan A, Rao TS, Joshi HM. Phage therapy in the Covid-19 era: Advantages over antibiotics. Curr Res Microb Sci 2022;:100115. [PMID: 35187507 DOI: 10.1016/j.crmicr.2022.100115] [Reference Citation Analysis]
10 Maronek M, Link R, Ambro L, Gardlik R. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease. Cells 2020;9:E1013. [PMID: 32325706 DOI: 10.3390/cells9041013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
11 Jończyk-Matysiak E, Łodej N, Kula D, Owczarek B, Orwat F, Międzybrodzki R, Neuberg J, Bagińska N, Weber-Dąbrowska B, Górski A. Factors determining phage stability/activity: challenges in practical phage application. Expert Rev Anti Infect Ther 2019;17:583-606. [PMID: 31322022 DOI: 10.1080/14787210.2019.1646126] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
12 Garvey M. Bacteriophages and the One Health Approach to Combat Multidrug Resistance: Is This the Way? Antibiotics (Basel) 2020;9:E414. [PMID: 32708627 DOI: 10.3390/antibiotics9070414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Górski A, Międzybrodzki R, Jończyk-Matysiak E, Borysowski J, Letkiewicz S, Weber-Dąbrowska B. The fall and rise of phage therapy in modern medicine. Expert Opin Biol Ther 2019;19:1115-7. [PMID: 31364887 DOI: 10.1080/14712598.2019.1651287] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
14 Ting DSJ, Galal M, Kulkarni B, Elalfy MS, Lake D, Hamada S, Said DG, Dua HS. Clinical Characteristics and Outcomes of Fungal Keratitis in the United Kingdom 2011-2020: A 10-Year Study. J Fungi (Basel) 2021;7:966. [PMID: 34829253 DOI: 10.3390/jof7110966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Vallianou N, Christodoulatos GS, Karampela I, Tsilingiris D, Magkos F, Stratigou T, Kounatidis D, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2022;12:56. [DOI: 10.3390/biom12010056] [Reference Citation Analysis]
16 Simon UK. An Instant Update on Viruses. The American Biology Teacher 2021;83:147-53. [DOI: 10.1525/abt.2021.83.3.147] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Khan A, Joshi H. Simple Two-step, High Yield Protocol for Isolation and Amplification of Bacteriophages Against Methicillin-resistant Staphylococcus Aureus (MRSA). Curr Protoc 2022;2:e395. [PMID: 35259286 DOI: 10.1002/cpz1.395] [Reference Citation Analysis]
18 Formanek PE, Dilling DF. Advances in the Diagnosis and Management of Invasive Fungal Disease. Chest 2019;156:834-42. [PMID: 31351046 DOI: 10.1016/j.chest.2019.06.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Li D, She X, Calderone R. The antifungal pipeline: the need is established. Are there new compounds? FEMS Yeast Research 2020;20:foaa023. [DOI: 10.1093/femsyr/foaa023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Tkhilaishvili T, Winkler T, Müller M, Perka C, Trampuz A. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2019;64:e00924-19. [PMID: 31527029 DOI: 10.1128/AAC.00924-19] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 13.3] [Reference Citation Analysis]
21 Suh GA, Lodise TP, Tamma PD, Knisely JM, Alexander J, Aslam S, Barton KD, Bizzell E, Totten KMC, Campbell JL, Chan BK, Cunningham SA, Goodman KE, Greenwood-Quaintance KE, Harris AD, Hesse S, Maresso A, Nussenblatt V, Pride D, Rybak MJ, Sund Z, van Duin D, Van Tyne D, Patel R; Antibacterial Resistance Leadership Group. Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob Agents Chemother 2022;66:e0207121. [PMID: 35041506 DOI: 10.1128/AAC.02071-21] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
22 Van Dyck K, Pinto RM, Pully D, Van Dijck P. Microbial Interkingdom Biofilms and the Quest for Novel Therapeutic Strategies. Microorganisms 2021;9:412. [PMID: 33671126 DOI: 10.3390/microorganisms9020412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Żaczek M, Górski A, Weber-dąbrowska B, Letkiewicz S, Fortuna W, Rogóż P, Pasternak E, Międzybrodzki R. A Thorough Synthesis of Phage Therapy Unit Activity in Poland—Its History, Milestones and International Recognition. Viruses 2022;14:1170. [DOI: 10.3390/v14061170] [Reference Citation Analysis]